Arovella Therapeutics Ltd has released a press release.
Business development update
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- SUDA granted Canadian Patent for SUD-002
- Bergen Funding
- To Acquire Major Australian Medical Products Distributor
- Raises $5 million in Placement
- Signs International Purchase Agreement
Later from Arovella Therapeutics
- Update on HC Berlin Pharma
- Technology patent application
- SUDA Enters Licensing Agreement For ZolpiMist in China
- SUDA presents data on novel technology
- Suspension from official quotation
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics